The study followed 47,000 women in Sweden between the ages of 29 and 49 over 20 years, with 1,500 of them developing breast or bowel cancer. The...

2 August 2019

8 February 2019 New research from Stanford University has found that high levels of CD24 found on the surface of cancer cells can stop immune...

2 August 2019

31 July 2019 The Scottish Government has announced that a review of the Scottish Breast Screening Programme is to be carried out....

31 July 2019

17 July 2019 The National Institute for Health and Care Excellence (NICE) has today (17 July 2019) announced its decision to approve ribociclib...

19 July 2019

The National Institute for Health and Care Excellence (NICE) has today (17 July 2019) announced its decision to approve ribociclib in combination...

18 July 2019

8 July 2019 The Scottish Medicines Consortium (SMC) has today (8 July 2019) announced its decision to approve palbociclib in combination with...

8 July 2019

3 June 2019 The new Interim NHS People Plan was launched on Monday 3 June 2019 to address the workforce challenges the health service is...

6 June 2019

Ribociclib (Kisqali, Novartis) is one of a class of drugs known as CDK4/6 inhibitors, which have recently been introduced to NHS care and work by...

3 June 2019

The Scottish Medicines Consortium (SMC) has today (13 May 2019) announced its decision to approve breast cancer drug abemaciclib as part of two new...

13 May 2019